572 related articles for article (PubMed ID: 27869804)
1. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.
Cramer SL; Saha A; Liu J; Tadi S; Tiziani S; Yan W; Triplett K; Lamb C; Alters SE; Rowlinson S; Zhang YJ; Keating MJ; Huang P; DiGiovanni J; Georgiou G; Stone E
Nat Med; 2017 Jan; 23(1):120-127. PubMed ID: 27869804
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth.
Kshattry S; Saha A; Gries P; Tiziani S; Stone E; Georgiou G; DiGiovanni J
NPJ Precis Oncol; 2019; 3():16. PubMed ID: 31231686
[TBL] [Abstract][Full Text] [Related]
3. Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition.
Saha A; Zhao S; Kindall A; Wilder C; Friedman CA; Clark R; Georgiou G; Stone E; Kidane D; DiGiovanni J
J Exp Clin Cancer Res; 2023 May; 42(1):119. PubMed ID: 37170264
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic Cancer.
Saha A; Zhao S; Chen Z; Georgiou G; Stone E; Kidane D; DiGiovanni J
Mol Ther; 2021 Feb; 29(2):775-787. PubMed ID: 33091613
[TBL] [Abstract][Full Text] [Related]
5. Cysteine depletion induces pancreatic tumor ferroptosis in mice.
Badgley MA; Kremer DM; Maurer HC; DelGiorno KE; Lee HJ; Purohit V; Sagalovskiy IR; Ma A; Kapilian J; Firl CEM; Decker AR; Sastra SA; Palermo CF; Andrade LR; Sajjakulnukit P; Zhang L; Tolstyka ZP; Hirschhorn T; Lamb C; Liu T; Gu W; Seeley ES; Stone E; Georgiou G; Manor U; Iuga A; Wahl GM; Stockwell BR; Lyssiotis CA; Olive KP
Science; 2020 Apr; 368(6486):85-89. PubMed ID: 32241947
[TBL] [Abstract][Full Text] [Related]
6. Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability.
Sha LK; Sha W; Kuchler L; Daiber A; Giegerich AK; Weigert A; Knape T; Snodgrass R; Schröder K; Brandes RP; Brüne B; von Knethen A
Free Radic Biol Med; 2015 Jun; 83():77-88. PubMed ID: 25687825
[TBL] [Abstract][Full Text] [Related]
7. Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism.
Liu J; Chen G; Pelicano H; Liao J; Huang J; Feng L; Keating MJ; Huang P
Oncotarget; 2016 Nov; 7(44):71378-71389. PubMed ID: 27655686
[TBL] [Abstract][Full Text] [Related]
8. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death.
Banjac A; Perisic T; Sato H; Seiler A; Bannai S; Weiss N; Kölle P; Tschoep K; Issels RD; Daniel PT; Conrad M; Bornkamm GW
Oncogene; 2008 Mar; 27(11):1618-28. PubMed ID: 17828297
[TBL] [Abstract][Full Text] [Related]
9. L-cyst(e)ine requirements of malignant cells and progress toward depletion therapy.
Uren JR; Lazarus H
Cancer Treat Rep; 1979 Jun; 63(6):1073-9. PubMed ID: 466647
[TBL] [Abstract][Full Text] [Related]
10. Tissue glutathione as a cyst(e)ine reservoir during cystine depletion in growing rats.
Cho ES; Johnson N; Snider BC
J Nutr; 1984 Oct; 114(10):1853-62. PubMed ID: 6481481
[TBL] [Abstract][Full Text] [Related]
11. Cyst(e)inase-Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer.
Kerimoglu B; Lamb C; McPherson RD; Ergen E; Stone EM; Ooi A
Mol Cancer Ther; 2022 Mar; 21(3):419-426. PubMed ID: 35086957
[TBL] [Abstract][Full Text] [Related]
12. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
[TBL] [Abstract][Full Text] [Related]
13. The viability of primary hepatocytes is maintained under a low cysteine-glutathione redox state with a marked elevation in ophthalmic acid production.
Lee J; Kang ES; Kobayashi S; Homma T; Sato H; Seo HG; Fujii J
Exp Cell Res; 2017 Dec; 361(1):178-191. PubMed ID: 29079265
[TBL] [Abstract][Full Text] [Related]
14. The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia.
Cunningham A; Oudejans LL; Geugien M; Pereira-Martins DA; Wierenga ATJ; Erdem A; Sternadt D; Huls G; Schuringa JJ
Blood Adv; 2024 Jan; 8(1):56-69. PubMed ID: 37906522
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-mediated depletion of serum l-Met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity.
Lu WC; Saha A; Yan W; Garrison K; Lamb C; Pandey R; Irani S; Lodi A; Lu X; Tiziani S; Zhang YJ; Georgiou G; DiGiovanni J; Stone E
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13000-13011. PubMed ID: 32434918
[TBL] [Abstract][Full Text] [Related]
16. Dosing Time-Dependent Changes in the Anti-tumor Effect of xCT Inhibitor Erastin in Human Breast Cancer Xenograft Mice.
Shiromizu S; Yamauchi T; Kusunose N; Matsunaga N; Koyanagi S; Ohdo S
Biol Pharm Bull; 2019; 42(11):1921-1925. PubMed ID: 31685775
[TBL] [Abstract][Full Text] [Related]
17. The X
Zheng Z; Luo G; Shi X; Long Y; Shen W; Li Z; Zhang X
Cell Oncol (Dordr); 2020 Feb; 43(1):95-106. PubMed ID: 31617161
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glutathione biosynthesis alters compartmental redox status and the thiol proteome in organogenesis-stage rat conceptuses.
Harris C; Shuster DZ; Roman Gomez R; Sant KE; Reed MS; Pohl J; Hansen JM
Free Radic Biol Med; 2013 Oct; 63():325-37. PubMed ID: 23736079
[TBL] [Abstract][Full Text] [Related]
19. Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer.
Sendo K; Seino M; Ohta T; Nagase S
Oncotarget; 2022; 13():224-236. PubMed ID: 35106124
[TBL] [Abstract][Full Text] [Related]
20. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation.
Shih AY; Erb H; Sun X; Toda S; Kalivas PW; Murphy TH
J Neurosci; 2006 Oct; 26(41):10514-23. PubMed ID: 17035536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
